SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-007260
Filing Date
2020-01-27
Accepted
2020-01-27 19:01:46
Documents
1
Period of Report
2020-01-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm205922d1_4.html 4  
1 OWNERSHIP DOCUMENT tm205922d1_4.xml 4 7876
  Complete submission text file 0001104659-20-007260.txt   9320
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9360 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address
Weyer Christian (Reporting) CIK: 0001493811 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 20551021